Breast hyperplasia
Fibrocystic breast disease is the most common breast disease in women, and its incidence ranks first among breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age of onset is getting younger and younger. Fibrocystic breast disease is the physiological proliferation and incomplete restoration of normal breast lobules, and the normal structure of the breast is disordered. It is a pathological hyperplasia. It is neither an inflammatory nor a tumor disease. It is more common in women aged 30-50, with the peak incidence at 35-40 years old.
-
Site of disease:
breast -
Infectious :
Not contagious -
Frequent population:
Women aged 30-50 -
Related symptoms:
Breast pain nodule cyst premenstrual breast pain axillary pain -
Concurrent disease:
Related Drugs
Prunella Vulgaris Paste
Manufacturer:
Nanjing Tongrentang Pharmaceutical Co., Ltd.
Prunella Vulgaris Paste
Manufacturer:
Beijing Dongsheng Pharmaceutical Co., Ltd.
Prunella Vulgaris Paste
Manufacturer:
Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd.
Prunella Vulgaris Paste
Manufacturer:
Wuhanbayseng Pharmaceutical Co., Ltd.
Quyu Sanjie Capsule
Manufacturer:
Hengtuo Group Guangxi Shengkang Pharmaceutical Co., Ltd.
Rukuaixiao granules
Manufacturer:
Anguo Yadong Biological Pharmaceutical Co., Ltd.
Breast mass elimination tablets
Manufacturer:
Jiangxi Doctoral Pharmaceutical Co., Ltd.
Rukuaixiao Capsules
Manufacturer:
Ankang Chia Tai Pharmacetucial Co., Ltd.
Rupikang Capsules
Manufacturer:
Yichun Wujiashen Pharmaceutical Co., Ltd.
Related Ingredients